Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In September: Earnings Summary

TRACON Pharmaceuticals

03/11/2021 21:54

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 38 cents​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 32 cents per share.
* Reported revenue was zero​;  analysts expected $57.14
thousand. 
* TRACON Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 38 cents​.
* The mean earnings estimate of analysts had fallen by
about 5.1% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* TRACON Pharmaceuticals Inc shares had fallen by 3.6% this
quarter and lost 68.1% so far this year.
* The company reported a quarterly loss of $6.95 million.
* Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $11.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 3 at 09:54 p.m.
 ​All figures in US dollars unless otherwise stated